| Recruiting | A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Dise NCT07412691 | BeOne Medicines | Phase 1 |
| Enrolling By Invitation | Diagnosis Evaluation Made by Artificial Inteligence in Response to a Request Made by General Praticioner on OM NCT07341906 | Centre Hospitalier Universitaire de Nice | — |
| Recruiting | An Observational Study to Assess Objective Skin Pigmentation Variation. NCT07091604 | Leiden University Medical Center | — |
| Recruiting | Skin Reactions Related to Thoracic Implantable Chamber Dressings NCT07158879 | Institut Curie | — |
| Recruiting | A Study to Learn About the Safety and Efficacy of the Drug Oleogel-S10 in Japanese Patients With Epidermolysis NCT06917690 | Chiesi Farmaceutici S.p.A. | Phase 3 |
| Recruiting | Herbal Ointment in Treating Atopic Dermatitis Topically NCT06850311 | En Chu Kong Hospital | Phase 2 / Phase 3 |
| Recruiting | Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) NCT06563323 | Oregon Health and Science University | Phase 2 |
| Recruiting | Deep Phenotyping of CIndU NCT07359430 | Centre for Human Drug Research, Netherlands | — |
| Recruiting | Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Non NCT06674980 | C5 Biomedical | N/A |
| Recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) NCT06353087 | Pfizer | — |
| Completed | Single-cell Transcriptome Identification of UV- and Visible-light-induced Genes in Human Melanocytes in Vivo NCT05780606 | Centre Hospitalier Universitaire de Nice | N/A |
| Recruiting | Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases NCT06387654 | University Hospital, Toulouse | — |
| Recruiting | The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around NCT06279143 | Vejle Hospital | — |
| Recruiting | Digital Toolkit for Skin Diseases in LMICs: Part 2 NCT06292260 | Tulane University | N/A |
| Unknown | Digital Versus Telephone Symptom Assessment and Triage in Primary Care NCT06092866 | Region Skane | N/A |
| Completed | Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) NCT04901325 | Oregon Health and Science University | Phase 2 |
| Completed | To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis NCT06061471 | Akeso | Phase 2 |
| Recruiting | OCT Vibrography for Biomechanical Properties of Tissues NCT05759780 | Massachusetts General Hospital | N/A |
| Completed | The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in No NCT05919810 | Integrative Skin Science and Research | N/A |
| Recruiting | Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders NCT05649098 | Northwestern University | EARLY_Phase 1 |
| Completed | A Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Moderate to Severe Plaque Psoriasis NCT06066125 | Akeso | Phase 3 |
| Recruiting | A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata NCT05723198 | Eli Lilly and Company | Phase 3 |
| Recruiting | Multi-modal Quantitative Imaging of the Skin NCT06989216 | HJN Sverige AB/Neko Health | — |
| Active Not Recruiting | A Herbal Compound for Psoriasis NCT06301997 | Fasa University of Medical Sciences | Phase 2 |
| Completed | Pilot Study: AI Algorithm for Dermatology Referral Optimization NCT06228014 | AI Labs Group S.L | — |
| Completed | VIO Imaging for Skin Tissue Assessment (VISTA) NCT05619471 | Enspectra Health | N/A |
| Recruiting | Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? NCT05102396 | Samantha Rodrigues Camargo Neves de Moura | Phase 2 |
| Unknown | Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases NCT05488860 | Xiangya Hospital of Central South University | N/A |
| Completed | Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) NCT05469464 | UNION therapeutics | Phase 2 |
| Completed | Biofeedback for Psoriasis NCT05506644 | Bastyr University | N/A |
| Active Not Recruiting | Lymphaticovenous Anastomosis as Treatment for Lymphedema NCT05441943 | Odense University Hospital | N/A |
| Unknown | A Multi-centric Clinical Trial in China for Skin Diseases Intelligent Diagnosis and Treatment System NCT05463523 | Xiangya Hospital of Central South University | — |
| Active Not Recruiting | Trem-1 and Ultraviolet Radiation-induced Immune Suppression NCT05020496 | University of Alabama at Birmingham | EARLY_Phase 1 |
| Completed | Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion NCT06237036 | AI Labs Group S.L | — |
| Active Not Recruiting | Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLA NCT05185258 | Aarhus University Hospital | Phase 4 |
| Unknown | Digital Toolkit for Skin Diseases in LMICs NCT05300399 | Tulane University | N/A |
| Completed | Study to Assess the Efficacy and Safety of Orismilast in Psoriasis NCT05190419 | UNION therapeutics | Phase 2 |
| Completed | Understanding Ayurveda Disease Conditions and Treatment Responses NCT06167226 | Ayurai Private Limited | — |
| Completed | Evaluation of Cicaplast in Subjects With Skin Irritation NCT05767333 | Cosmetique Active International | — |
| Terminated | BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort NCT04818138 | Women's College Hospital | N/A |
| Completed | Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo NCT04971200 | Premier Specialists, Australia | EARLY_Phase 1 |
| Completed | Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown NCT05038982 | Johns Hopkins University | Phase 2 |
| Terminated | Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety o NCT04775316 | BSN Medical GmbH | — |
| Completed | OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women NCT04834167 | Universiti Tunku Abdul Rahman | N/A |
| Completed | Economic Evaluation in Teledermatology NCT04378296 | Antonio Lopez Villegas | N/A |
| Completed | A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With NCT04760314 | Eli Lilly and Company | Phase 3 |
| Completed | Substance P Challenge in Healthy Participants NCT04676763 | GlaxoSmithKline | N/A |
| Withdrawn | Iontophoresis in Psoriasis NCT03979664 | Wake Forest University Health Sciences | EARLY_Phase 1 |
| Completed | Using AI as a Diagnostic Decision Support Tool to Help the Diagnosis of Skin Disease in Primary Healthcare in NCT04562168 | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | N/A |
| Completed | Rare Benign Lesion of Peins NCT04725292 | Assiut University | — |
| Completed | Deep Learning on 3D Cellular-resolution Tomogram NCT04679961 | Mackay Memorial Hospital | — |
| Terminated | Deep Neural Networks on the Accuracy of Skin Disease Diagnosis in Non-Dermatologists NCT04636164 | Pyoeng Gyun Choe | N/A |
| Completed | An Open Label Study for Palmar Hyperhydrosis NCT04906655 | Pariser, Robert J., M.D. | Phase 2 |
| Withdrawn | A Novel Skin Barrier Protectant for Acute Radiodermatitis NCT04593914 | Jessa Hospital | N/A |
| Completed | Joovvin' for Your Skin Health Study NCT04471896 | ProofPilot | N/A |
| Completed | Surgical Hand Antisepsis With Propan-ol-1 60% Per Rubbing and Scrubbing NCT04446923 | Universidad Complutense de Madrid | Phase 4 |
| Completed | Groups for Specific vs Mixed Diagnosis Patients of Chronic Conditions NCT05402358 | University of Stirling | — |
| Completed | A Project to Study Probiotic Beauty Products on Skin Improvement NCT05276661 | Chia Nan University of Pharmacy ＆ Science | N/A |
| Completed | Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry F NCT04265521 | Biocool AB | N/A |
| Completed | Effect of Lipikar Baume AP+M on Quality of Life and Pain of Adults With Dryness or Severe Xerosis NCT05765461 | Cosmetique Active International | — |
| Unknown | Nutraceuticals and Functional Foods NCT05509075 | University of Catanzaro | — |
| Completed | Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda NCT04144491 | VU University of Amsterdam | N/A |
| Unknown | Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer NCT04138342 | Al-Azhar University | Phase 1 |
| Unknown | A Nutritional Trial on Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) NCT03990220 | VU University of Amsterdam | — |
| Completed | A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts NCT03981822 | Verrica Pharmaceuticals Inc. | Phase 2 |
| Terminated | Effects of Temperature Control Liner Materials on Long-Term Outcomes of Prothesis Use NCT03428815 | Goeran Fiedler | N/A |
| Completed | Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis NCT03832738 | Akros Pharma Inc. | Phase 2 |
| Completed | Efficacy of High-intensity Laser in Jaccoud's Arthropathy in Systemic Lupus Erythematosus NCT04244539 | Jouf University | N/A |
| Completed | the Evaluation of the Efficacy of TCI66207 on the Skin. NCT05143034 | TCI Co., Ltd. | N/A |
| Completed | Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe At NCT03720470 | Pfizer | Phase 3 |
| Completed | Effect of Benralizumab in Atopic Dermatitis NCT03563066 | McMaster University | Phase 2 |
| Completed | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Se NCT03627767 | Pfizer | Phase 3 |
| Completed | Laser Therapy Versus Narrow Band Ultraviolet B for the Treatment of Acne Vulgaris NCT04254601 | Cairo University | N/A |
| Completed | Non-Linear Imaging of Skin In Vivo NCT05410964 | Enspectra Health | — |
| Completed | Cantharidin and Occlusion in Verruca Epithelium NCT03487549 | Verrica Pharmaceuticals Inc. | Phase 2 |
| Unknown | Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III NCT03433222 | VA Northern California Health Care System | Phase 1 |
| Completed | Early Feasibility Study: Application of OCT Imaging in Dermatology NCT04066582 | Mackay Memorial Hospital | — |
| Terminated | Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis NCT03358290 | Akros Pharma Inc. | Phase 2 |
| Completed | Effects of Guided Written Disclosure Protocol on Psychological Distress and Positive Functioning in Persons Wi NCT04739228 | European University of Rome | N/A |
| Active Not Recruiting | Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer NCT03818620 | Barco NV | — |
| Completed | Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria NCT02824393 | Celal Bayar University | EARLY_Phase 1 |
| Completed | Transepidermal Application of Metilaminolevulinate in Daylight PDT in the Treatment of Photodamaged Skin NCT03963765 | Universidade Federal Fluminense | N/A |
| Active Not Recruiting | Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypert NCT02682511 | Cumberland Pharmaceuticals | Phase 2 |
| Completed | Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasi NCT03018509 | Akros Pharma Inc. | Phase 1 |
| Completed | A Study of LY3041658 in Participants With Skin Diseases NCT02896868 | Eli Lilly and Company | Phase 1 |
| Unknown | Study of VF001-DP in Patients With Chronic Venous Leg Ulcers NCT02973893 | Factor Therapeutics Ltd. | Phase 2 |
| Completed | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Spec NCT02916888 | Yale University | — |
| Unknown | The Lolland-Falster Health Study NCT02482896 | Region Sjælland | — |
| Completed | Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP NCT02500758 | Ricardo Becerro de Bengoa Vallejo | N/A |
| Completed | The Impact of a Dermatology Information Source on Skin Problem Outcomes in Primary Care NCT02922738 | University of Vermont | N/A |
| Completed | Observational Study to Assess Safety and Utility Pattern of Topical Steroids NCT02377557 | Hanyang University | — |
| Completed | A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions NCT02052752 | GlaxoSmithKline | Phase 4 |
| Completed | A Randomized, Open-label, Comparative Study to Evaluate an Intermittent Dosing Regimen of Fluticasone Propiona NCT01915914 | GlaxoSmithKline | Phase 4 |
| Completed | Online Question-answering and Conventional Consultation With a Dermatologist NCT01969422 | University of Zurich | — |
| Completed | Adaption of the Skin Sun Sensitivity Scale NCT01975038 | Northwestern University | — |
| Unknown | Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC NCT01917279 | Binghe Xu | Phase 3 |
| Completed | Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis NCT01938599 | AmDerma | Phase 2 |
| Completed | Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis NCT01865032 | U.S. Army Medical Research and Development Command | — |
| Completed | Minocycline Bioequivalence Study NCT01938508 | GlaxoSmithKline | Phase 1 |
| Recruiting | Effects of Treatments on Atopic Dermatitis NCT01631617 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Phase 2 |
| Completed | A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis NCT01490632 | Eli Lilly and Company | Phase 2 |
| Unknown | The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction NCT01427400 | University of British Columbia | Phase 4 |
| Withdrawn | Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infection NCT00911573 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 NCT01305187 | Merz Pharmaceuticals GmbH | Phase 4 |
| Completed | Efficacy of Intraoperative Surgical Scrubbing in Reducing Bacterial Load After Nail Removal Surgery NCT01330706 | Universidad Complutense de Madrid | Phase 4 |
| Completed | CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial NCT00847912 | VA Office of Research and Development | Phase 4 |
| Completed | Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs NCT00488293 | US Department of Veterans Affairs | N/A |
| Completed | China Registration Study in Patients With Skin Infections NCT00772447 | AstraZeneca | Phase 3 |
| Completed | Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women NCT00541931 | Stanford University | N/A |
| Unknown | Infections Caused by ESbL-Producing Enterobacteriaceae in Italy NCT00404625 | University of Siena | — |
| Completed | Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR NCT00240682 | Centre Hospitalier of Chartres | Phase 2 |
| Completed | Studying Normal Breast Tissue and Cancer Risk NCT00341692 | National Cancer Institute (NCI) | — |
| Completed | A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer NCT00050427 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | Topical Therapy for Prevention of Infections in Preterm Infants NCT00162747 | Johns Hopkins Bloomberg School of Public Health | Phase 4 |
| Completed | Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers NCT00001164 | National Cancer Institute (NCI) | — |
| Completed | A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers NCT00186563 | Martin Angst | N/A |
| Completed | Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis NCT00669123 | Bioiberica | Phase 4 |